With a slower economy and higher unemployment, construction took a hit in 2025. Experts and research firms forecast a year of stabilization and recovery for commercial real estate in 2026. Here's what ...

Royalty funding market reached record high of $10 billion in 2025, powered by synthetic royalties Royalty Pharma maintained industry leadership ...

The Centers for Medicare and Medicaid Services (CMS) has revealed the prices for the second batch of 15 drugs going through Medicare's negotiation process, promising a 44% cut that will save around ...

Ranked by Metro square feet broken ground on, 2023-2025 Ranked by 2025 Central Ohio remodeling sales volume Showcase your company news with guaranteed exposure both in print and online Get ready for ...

The World Economic Outlook (WEO) database contains selected macroeconomic data series from the statistical appendix of the World Economic Outlook report, which presents the IMF staff's analysis and ...

Welcome to Fierce Pharma's regulatory tracker for the first half of 2026. On this page, we're recording the regulatory progress of in-market products, including expansions into key geographies and new ...

GSK has secured approval in China for Trelegy Ellipta as a maintenance treatment for adults with asthma, adding to its existing indication in COPD and making it the only single inhaler triple therapy ...